Analyst Calls: ACOR, CHKM, CPB, ENV, GDOT, GR, GSK, MFE, NOK, OXY, PXD, SI ...


Analyst Upgrades

  • FBR Capital upgraded Pioneer Natural (PXD) to outperform from market perform and raised its price target for shares to $85 from $60. The firm upgraded shares on expectations that returns from the company's Spraberry field will increase materially.
  • Baird upgraded Acroda Therapeutics (ACOR) to outperform from neutral based on valuation and a new survey that indicates a strong uptake for Ampyra and improvements on the reimbursement front. The firm has a $40 target on the stock.
  • Morgan Stanley upgraded Nokia (NOK) to overweight from underweight based on checks that indicate strong orders and less than expected discounting for its upcoming N8 smartphone.
  • GlaxoSmithKline (GSK) and British American Tobacco (BTI) were upgraded to buy from neutral at BofA/Merrill.
  • Quality Systems (QSII) was upgraded to outperform from market perform at William Blair.
  • Siemens (SI) was upgraded to buy from neutral at UBS.

Analyst Downgrades

  • Janney Montgomery downgraded Campbell Soup (CPB) to neutral from buy with a $37 price target, citing the company's guidance and acquisition risk.
  • Goldman downgraded Goodrich (GR) to neutral from buy and has an $85 price target on the stock. The firm cites relative valuation for the rating change.
  • Mid-America (MAA), Vornado (VNO) and AvalonBay (AVB) were downgraded to market perform from outperform at Keefe Bruyette, citing valuation and a lack of catalysts.
  • McAfee (MFE) was downgraded to equal weight from overweight at Barclays.
  • Holly Energy (HEP) was downgraded to neutral from buy at BofA/Merrill.
  • CommVault (CVLT) was downgraded to market perform from outperform at Morgan Keegan.

Analyst Initiations

  • Green Dot (GDOT) was initiated with an overweight rating and $60 target at JPMorgan and Morgan Stanley and with an overweight rating and $57 target at Piper Jaffray.
  • Chesapeake Midstream (CHKM) was initiated with an overweight rating and $26 target at Barclays. Shares were also initiated at Goldman with a neutral rating and $25 target, with an overweight rating and $28 target at Morgan Stanley and with a buy rating and $26.50 target at UBS.
  • Envestnet (ENV) was initiated with an outperform rating and $12 target at RBC Capital, with an equal weight rating and $11 target at Barclays and with an overweight rating and $15 target at Morgan Stanley.
  • Auriga initiated Mettler-Toledo (MTD) with a hold rating and $120 target.
  • Susquehanna started Occidental Petroleum (OXY) with a positive rating and $98 target.
  • Citigroup assumed BMC Software (BMC) with a buy rating and $45 target.
Symbol Lookup
IndexesChangePrice
DJIA-8.9415,298.23
NASDAQ-7.193,456.11
S&P 500-5.821,649.53

Last updated: May 23, 2013: 02:09 PM

Hot Stocks

General Electric

23.565-0.295(-1.24)

Alcoa

8.50-0.19(-2.19)

Apple Inc

442.04+0.686(+0.16)

Google Inc 'A'

882.405-7.015(-0.79)

Bank of America

13.245-0.065(-0.49)

Wal-Mart Stores

76.46-0.57(-0.74)

Exxon Mobil Corp

91.92-0.27(-0.29)

Ford

14.82-0.15(-1.00)

Citigroup

50.40-0.60(-1.18)

IBM

207.59+0.60(+0.29)

Yahoo

25.90-0.64(-2.41)

Starbucks

63.34-0.81(-1.26)

Microsoft

34.26-0.35(-1.01)

Home Depot

78.80-0.89(-1.12)

DailyFinance Headlines

Benzinga Headlines

TheFlyOnTheWall.com Headlines

BioHealth Investor Headlines

WalletPop Headlines

DailyFinance BlackBerry App

My Portfolios

Track your stocks here!

Find out why more people track their portfolios on AOL Money & Finance then anywhere else.

BloggingStocks Partners

More from AOL Money & Finance

BioHealth Investor Headlines

Page Loaded in 1369332567856 ms.